Skip to content
Movie Casting Call
Author:
Kelun-Biotech
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
May 30, 2026
←
Previous Page
1
2